The molecular epidemiology of parvovirus B19

Reviews and Research in Medical Microbiology

Volumn 8, Issue 1, 1997, Pages 21-31

  Kerr, Jonathan R ^a   Umene, Kenichi ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Molecular epidemiology; Parvovirus B19

Indexed keywords

VIRUS DNA;

APLASTIC ANEMIA; ARTHROPATHY; BONE MARROW DEPRESSION; BRAIN DISEASE; CELL CULTURE; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; ERYTHROCYTE LIFESPAN; EUROPE; FETUS HYDROPS; GENOTYPE; GLOMERULONEPHRITIS; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; JAPAN; MENINGITIS; MOLECULAR CLONING; MYOCARDITIS; NEPHROTIC SYNDROME; PARVOVIRUS; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; UNITED STATES; VASCULITIS; VIRUS CULTURE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0031016763     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199701000-00003     Document Type: Review

References (50)

1. Cossart YE, Field AM, Cant B, Widdow D. Parvovirus-like particles in human sera. Lancet 1975; i: 72-73.
2. Pattison JR, Jones SE, Hodgson J et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981; 1: 664-665.
3. Anderson MJ, Jones SE, Fisher-Hock SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease). Lancet 1983; i: 1378.
4. International Committee on Taxonomy of Viruses. Virus Taxonomy Update. Arch Virol 1993; 133: 491-495.
5. Brown KE, Green SW, O'Sullivan MG, Young NS. Cloning and sequencing of the simian parvovirus genome. Virology 1995; 210: 314-322.
6. Deiss V, Tratschin JD, Weitz M, Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 1990; 175: 247-254.
7. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell culture. Science 1986; 233: 883-886.
8. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 1987; 70: 384-391.
9. Ozawa K, Ayub J, Hao YS, Kurtzman GJ, Shimada T, Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 1987; 61: 2395-2406.
10. Luo W, Astell CR. A novel protein encoded by small RNAs of Parvovirus B19. Virology 1993; 195: 448-455.
11. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organisation of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986; 58: 921-936.
12. Ozawa K, Young N. Characterisation of capsid and non-capsid proteins of B19 parvovirus propogated in human erythroid bone marrow cell cultures. J Virol 1987; 61: 2627-2630.
13. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N. The gene encoding the non-structural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988; 62: 2884-2889.
14. Doerig C, Hirt B, Antonietti JP, Beard P. Non-structural protein of parvovirus B19 and minute virus of mice controls transcription. J Virol 1990; 64: 387-396.
15. Kawase M, Momoeda M, Young NS, Kajigaya S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 1995; 211: 359-366.
16. Kajigawa S, Shimada T, Fujita S, Young NS. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci USA 1989; 86: 7601-7605.
17. Clewley JP. Derivation and interpretation of viral nucleotide sequences from clinical specimens. Rev Med Microbiol 1995; 6: 26-38.
18. Parrish CR. Emergence, natural history and variation of canine, mink and feline parvovirus. Adv Virus Res 1990; 38: 403-450.
19. Truyen U, Gruenberg A, Chang S-F, Obermaier B, Veijalainen P, Parris CR. Evolution of the Feline-subgroup parvovirus and the control of canine host range in vivo. J Virol 1995; 69: 4702-4710.
20. Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg Camb 1983; 91: 113-130.
21. Cohen BJ, Buckley M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Micro 1988; 25: 151-153.
22. Gillespie SM, Gartter ML, Asch S et al. Occupational risk of human parvovirus B19 infection for school and daycare personnel during an outbreak of erythema infectiosum. J Am Med Assoc 1990; 263: 2061-2065.
23. McOmish F, Yap PL, Jordan A, Hart A, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood; a model system for screening by polymerase chain reaction. J Clin Micro 1993; 31: 323-328.
24. Mortimer PP, Luban NLC, Kelleher JF, Cohen BJ. Transmission of serum parvovirus like virus by clotting factor concentrates. Lancet 1983; ii: 482-484.
25. Anderson MJ, Higgins PG, Davis LR et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257-265.
26. Potter CG, Potter AC, Hatton CSR et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987; 79: 1486-1492.
27. Morey AL, Fleming KA. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol 1992; 82: 302-309.
28. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-117.
29. Brown KE, Hibbs JR, Gallinella G et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330: 1192-1196.
30. Young NS, Mortimer PP, Moore JG. Characterisation of a virus that causes transient aplastic crisis. J Clin Invest 1984; 73: 224-230.
31. Kerr JR. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996; 15: 10-29.
32. Morinet F, Tratschin JD, Perol Y, Siegl G. Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Arch Virol 1986; 90: 165-72.
33. Mori J, Beattie P, Melton DW, Cohen BJ, Clewley JP. Structure and mapping of the DNA of human parvovirus B19. J Gen Virol 1987; 68: 2797-2806.
34. Kerr JR, Curran MD, Moore JE et al. Genetic diversity in the non-structural gene of Parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing. J Virol Meth 1995; 53: 213-222.
35. Umene K, Nunoue T. A new genome type of human parvovirus B19 present in sera of patients with encephalopathy. J Gen Virol 1995; 76: 2645-2651.
36. Umene K, Nunoue T. The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence. J Gen Virol 1990; 71: 983-986.
37. Cotmore SF, Tattersall P. Characterisation and molecular cloning of a human parvovirus genome. Science 1984; 226: 1161-1165.
38. Blundell MC, Beard C, Astell CR. In vitro identification of a B19 parvovirus promoter. Virology 1987; 157: 534-538.
39. Umene K, Nunoue T. Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognising four or five base pairs and partial nucleotide sequencing: use of sequence variability in virus classification. J Gen Virol 1991; 72: 1997-2001.
40. Gallinella G, Venturoli S, Gentilomi G, Musiani M, Zerbini M. Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus. Arch Virol 1995; 140: 1119-1125.
41. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Human mutation 1993; 2: 338-346.
42. Parrish CR, Have P, Foreyt WJ, Evermann JF, Senda M, Carmichael LE. The global spread and replacement of canine parvovirus strains. J Gen Virol 1988; 69: 1111-1116.
43. Fridell E, Trojnar J, Wahren B. A new peptide for human parvovirus B19 antibody detection. Scand J Infect Dis 1989; 21: 597-603.
44. Caul EO, Usher MJ, Burton PA. Intrauterine infection with human parvovirus B19; a light and electron microscopy study. J Med Virol 1988; 24: 55-66.
45. Clewley JP, Cohen BJ, Field AM. Detection of parvovirus B19 DNA, antigens, and particles in the human fetus. J Med Virol 1987; 23: 367-376.
46. Umene K, Nunoue T. Partial nucleotide sequencing and characterisation of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukaemia. J Med Virol 1993; 39: 333-339.
47. Kerr JR, Curran MD, Moore JE, Murphy PG. Parvovirus B19 infection; persistence and genetic variation. Scand J Infect Dis 1995; 27: 551-557.
48. Gottschalck E, Alexandersen S, Cohn A, Poulsen LA, Bloom ME, Aasted B. Nucleotide sequence analysis of aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J Virol 1991; 65: 4378-4386.
49. Balfour HH, Schiff GM, Bloom JE. Encephalitis associated with erythema infectiosum. J Pediatr 1970; 77: 133-136.
50. Watanabe T, Satoh M, Oda Y. Human parvovirus B19 encephalopathy. Arch Dis Child 1994; 70: 71.